
Ainnocence provides an AI-driven platform to speed up drug discovery and reduce discovery costs. The system combines virtual screening, scientific intelligence, and molecular generative AI. It performs high-throughput computational screening, evaluating up to 10^10 protein sequences or compounds within hours, guiding wet-lab experiments with high hit rates. The platform supports small molecules, antibodies, CAR-T and other modalities for multi-objective pharmacological optimization. This B2B technology aims to cut development time and costs for biotech and pharmaceutical companies.

Ainnocence provides an AI-driven platform to speed up drug discovery and reduce discovery costs. The system combines virtual screening, scientific intelligence, and molecular generative AI. It performs high-throughput computational screening, evaluating up to 10^10 protein sequences or compounds within hours, guiding wet-lab experiments with high hit rates. The platform supports small molecules, antibodies, CAR-T and other modalities for multi-objective pharmacological optimization. This B2B technology aims to cut development time and costs for biotech and pharmaceutical companies.
Founded: 2021
Headquarters / business centers: Silicon Valley (Mountain View), CA; Boston, MA
Product: Sequence-first generative AI platform for therapeutic discovery (small molecules, antibodies, cell therapies)
Scale claim: Virtual screening up to 10 billion candidates within hours
Stage (public record): Seed rounds recorded (two rounds listed in Crunchbase)
| Company |
|---|
Therapeutic discovery and synthetic biology (drug discovery R&D efficiency and multi-modal molecule/cell engineering).
2021
Biotechnology
Dealroom and Crunchbase list a seed entry in 2021; Crunchbase records two rounds but amounts are not publicly disclosed.
“Early investors listed on Dealroom include Genesis Capital and Iaso Ventures”
Company Description
Ainnocence is a cutting-edge biotech company specializing in AI-driven drug design. Leveraging a state-of-the-art third-generation AI system, Ainnocence enables rapid virtual screening and optimization of small molecules, antibodies, CAR-T cells, and other complex therapeutic modalities. The platform offers the ability to computationally screen up to 10 10 protein sequences or chemical compounds within hours, resulting in high hit rates and significant reductions in drug discovery time and costs. Ainnocence is committed to revolutionizing the drug design process and delivering innovative therapeutic solutions. For more information, visit ainnocence.com.
Role Description
This is a full-time remote role for a Research Assistant. The Research Assistant will conduct scientific research, perform data analysis, and support laboratory activities to contribute to ongoing projects. Responsibilities include gathering and analyzing data, preparing research reports, collaborating on experiments, and assisting in the interpretation of results. The Research Assistant will play a key role in advancing the company’s goals through meticulous research and collaboration with interdisciplinary teams.
Qualifications